Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial
评估新批准药物联合治疗方案对耐氟喹诺酮类药物多重耐药结核病（endTB-Q）：一项多国随机对照试验的研究方案
期刊:Trials
影响因子:2
doi:10.1186/s13063-023-07701-6
Patil, S B; Tamirat, M; Khazhidinov, K; Ardizzoni, E; Atger, M; Austin, A; Baudin, E; Bekhit, M; Bektasov, S; Berikova, E; Bonnet, M; Caboclo, R; Chaudhry, M; Chavan, V; Cloez, S; Coit, J; Coutisson, S; Dakenova, Z; De Jong, B C; Delifer, C; Demaisons, S; Do, J M; Dos Santos Tozzi, D; Ducher, V; Ferlazzo, G; Gouillou, M; Khan, U; Kunda, M; Lachenal, N; LaHood, A N; Lecca, L; Mazmanian, M; McIlleron, H; Moreau, M; Moschioni, M; Nahid, P; Osso, E; Oyewusi, L; Panda, S; Pâquet, A; Thuong Huu, P; Pichon, L; Rich, M L; Rupasinghe, P; Salahuddin, N; Sanchez Garavito, E; Seung, K J; Velásquez, G E; Vallet, M; Varaine, F; Yuya-Septoh, F J; Mitnick, C D; Guglielmetti, L
